The Spectrum and Frequency of Cystic Fibrosis Mutations in Albanian Patients

1. Sharma N, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet. 2013 Oct;45(10):1160–7. SharmaN Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene Nat Genet 2013 Oct 45 10 1160 7 Search in Google Scholar

2. Guo J, Garratt A, Hill A. Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros. 2022 May;21(3):456–462. doi: 10.1016/j.jcf.2022.01.009. Epub 2022 Feb 4. PMID: 35125294 GuoJ GarrattA HillA Worldwide rates of diagnosis and effective treatment for cystic fibrosis J Cyst Fibros 2022 May 21 3 456 462 10.1016/j.jcf.2022.01.009 Epub 2022 Feb 4. 35125294 Open DOISearch in Google Scholar

3. Bell SC, DeBoeck K, D Amaral M. New Pharmacological Approaches for Cystic Fibrosis: Promises, Progress, Pitfalls. Pharmacol Ther. 2015 Jan; 145:19–34 BellSC DeBoeckK AmaralM D New Pharmacological Approaches for Cystic Fibrosis: Promises, Progress, Pitfalls Pharmacol Ther 2015 Jan 145 19 34 Search in Google Scholar

4. The molecular genetic epidemiology of cystic fibrosis. Human Genetics Program, Chronic Diseases and Health Promotion, World Health Organization: Report of a joint meeting of WHO/ECFTN/ICF(M) A/ECFS; 2002. The molecular genetic epidemiology of cystic fibrosis. Human Genetics Program, Chronic Diseases and Health Promotion World Health Organization: Report of a joint meeting of WHO/ECFTN/ICF(M) A/ECFS 2002 Search in Google Scholar

5. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009 May 30; 373(9678):1891–904. O’SullivanBP FreedmanSD Cystic fibrosis Lancet 2009 May 30 373 9678 1891 904 Search in Google Scholar

6. www.ecfs.eu/ecfspr www.ecfs.eu/ecfspr Search in Google Scholar

7. Institute of Statistics Albania www.instat.gov.al Institute of Statistics Albania www.instat.gov.al Search in Google Scholar

8. CFTR2 31 August 2018. www.cftr2.org/mutation list CFTR2 31 August 2018 www.cftr2.org/mutation list Search in Google Scholar

9. European Cystic fibrosis society. Patient Registry. At-A-Glance report 2016 European Cystic fibrosis society. Patient Registry At-A-Glance report 2016 Search in Google Scholar

10. European Cystic fibrosis society. Patient Registry. At-A-Glance report 2021 European Cystic fibrosis society. Patient Registry At-A-Glance report 2021 Search in Google Scholar

11. Bobadilla JL1, Macek M Jr, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening. Hum Mutat. 2002 Jun; 19(6):575–606. BobadillaJL1 MacekMJr FineJP FarrellPM Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening Hum Mutat 2002 Jun 19 6 575 606 Search in Google Scholar

12. https://www.registroitalianofibrosicistica.it/documenti/servizi/rifc_at_a_glance_2021.pdf https://www.registroitalianofibrosicistica.it/documenti/servizi/rifc_at_a_glance_2021.pdf Search in Google Scholar

13. Terzic M, Jakimovska M, Fustik S, Jakovska T, Sukarova-Stefanovska E, Plaseska-Karanfilska D. Cystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy. Balkan Journal of Medical Genetics. 2019 Aug 28;22(1):35–40. TerzicM JakimovskaM FustikS JakovskaT Sukarova-StefanovskaE Plaseska-KaranfilskaD Cystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy Balkan Journal of Medical Genetics 2019 Aug 28 22 1 35 40 Search in Google Scholar

14. Radivojevic D, Djurisic M, Lalic T, Guc-Scekic M, Savic J, Minic P. Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis. Genet Test. 2004;8(3):276–280. et al. RadivojevicD DjurisicM LalicT Guc-ScekicM SavicJ MinicP Spectrum of cystic fibrosis mutations in Serbia and Montenegro and strategy for prenatal diagnosis Genet Test 2004 8 3 276 280 et al. Search in Google Scholar

15. Fustik S, Plaseska Karanfilska D, Terzikj M, Spirevska L, Stamatova A. Spectrum of CFTR mutations in Republic of North Macedonia European Respiratory Journal 2020 56: 2768; DOI: 10.1183/13993003.congress-2020.2768, FustikS Plaseska KaranfilskaD TerzikjM SpirevskaL StamatovaA Spectrum of CFTR mutations in Republic of North Macedonia European Respiratory Journal 2020 56 2768 10.1183/13993003.congress-2020.2768 Open DOISearch in Google Scholar

16. T. Dörk, M. Macek Jr., F. Mekus, B. Tümmler, J. Tzountzouris, T. Casals, et al. Characterization of a novel 21-kb deletion, CFTRdele2,3 (21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East EuropeHum Genet, 106 (2000), pp. 259–268 DörkT. MacekM.Jr. MekusF. TümmlerB. TzountzourisJ. CasalsT. Characterization of a novel 21-kb deletion, CFTRdele2,3 (21 kb), in the CFTR gene: a cystic fibrosis mutation of Slavic origin common in Central and East Europe Hum Genet 106 2000 259 268 Search in Google Scholar

17. Ikpa PT, Bijvelds MJ, De Jonge HR. Cystic fibrosis: toward personalized therapies. Int J Biochem Cell Biol 2014; 52:192–200 IkpaPT BijveldsMJ De JongeHR Cystic fibrosis: toward personalized therapies Int J Biochem Cell Biol 2014 52 192 200 Search in Google Scholar

18. Rubin JL1, O’Callaghan L2, Pelligra C3, Konstan MW4, Ward A3, Ishak JK5, Chandler C3, Liou TG6. Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor. TherAdvRespir Dis. 2019 Jan–Dec; 13:175 RubinJL1 O’CallaghanL2 PelligraC3 KonstanMW4 WardA3 IshakJK5 ChandlerC3 LiouTG6 Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor TherAdvRespir Dis 2019 Jan–Dec 13 175 Search in Google Scholar

19. Ponzano S, Nigrelli G, Fregonese L, Eichler I, Bertozzi F, Bandiera T, Galietta LJV3, Papaluca M1. A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators. Eur-Respir Rev. 2018 Apr 13; 27(148). PonzanoS NigrelliG FregoneseL EichlerI BertozziF BandieraT GaliettaLJV3 PapalucaM1 A European regulatory perspective on cystic fibrosis: current treatments, trends in drug development and translational challenges for CFTR modulators Eur-Respir Rev 2018 Apr 13 27 148 Search in Google Scholar